You just read:

Oncolytics Biotech® Inc. Announces Positive REOLSYIN® Clinical Trial Data Presented at ASCO Gastrointestinal Cancers Symposium

News provided by

Oncolytics Biotech Inc.

Jan 28, 2013, 06:30 EST